These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 33563157)

  • 1. Chitosan - A Potential Polymer to Prepare Anticancer Drug Delivery Systems: Patent Review.
    Kriplani P; Guarve K
    Recent Pat Anticancer Drug Discov; 2021; 16(2):249-257. PubMed ID: 33563157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan-modified nanocarriers as carriers for anticancer drug delivery: Promises and hurdles.
    Alhodieb FS; Barkat MA; Barkat HA; Hadi HA; Khan MI; Ashfaq F; Rahman MA; Hassan MZ; Alanezi AA
    Int J Biol Macromol; 2022 Sep; 217():457-469. PubMed ID: 35798082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Connecting the dots in drug delivery: A tour d'horizon of chitosan-based nanocarriers system.
    Pramanik S; Sali V
    Int J Biol Macromol; 2021 Feb; 169():103-121. PubMed ID: 33338522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biopolymeric alginate-chitosan nanoparticles as drug delivery carriers for cancer therapy.
    Bhunchu S; Rojsitthisak P
    Pharmazie; 2014 Aug; 69(8):563-70. PubMed ID: 25158565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan nanoparticles in drug therapy of infectious and inflammatory diseases.
    Rajitha P; Gopinath D; Biswas R; Sabitha M; Jayakumar R
    Expert Opin Drug Deliv; 2016 Aug; 13(8):1177-94. PubMed ID: 27087148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of Chitosan and its Derivatives in Nanocarrier Based Pulmonary Drug Delivery Systems.
    Dua K; Bebawy M; Awasthi R; Tekade RK; Tekade M; Gupta G; De Jesus Andreoli Pinto T; Hansbro PM
    Pharm Nanotechnol; 2017; 5(4):243-249. PubMed ID: 28786352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nano-Chitosan Particles in Anticancer Drug Delivery: An Up-to-Date Review.
    Kamath PR; Sunil D
    Mini Rev Med Chem; 2017; 17(15):1457-1487. PubMed ID: 28245780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan mediated targeted drug delivery system: a review.
    Patel MP; Patel RR; Patel JK
    J Pharm Pharm Sci; 2010; 13(4):536-57. PubMed ID: 21486530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of Important Polysaccharides in Drug Delivery.
    Huang G; Mei X; Xiao F; Chen X; Tang Q; Peng D
    Curr Pharm Des; 2015; 21(25):3692-6. PubMed ID: 25578889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan in cancer therapy: a dual role as a therapeutic agent and drug delivery system.
    Atmaca H; Oguz F; Ilhan S
    Z Naturforsch C J Biosci; 2024 May; 79(5-6):95-105. PubMed ID: 38478126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review on the applications of electrospun chitosan nanofibers for the cancer treatment.
    Shikhi-Abadi PG; Irani M
    Int J Biol Macromol; 2021 Jul; 183():790-810. PubMed ID: 33965480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eudragit, a Nifty Polymer for Anticancer Preparations: A Patent Review.
    Kriplani P; Guarve K
    Recent Pat Anticancer Drug Discov; 2022; 17(1):92-101. PubMed ID: 34645379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan-based Polymer Matrix for Pharmaceutical Excipients and Drug Delivery.
    Khan MIH; An X; Dai L; Li H; Khan A; Ni Y
    Curr Med Chem; 2019; 26(14):2502-2513. PubMed ID: 30259805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in chitosan films for controlled release of drugs.
    Mengatto LN; Helbling IM; Luna JA
    Recent Pat Drug Deliv Formul; 2012 Aug; 6(2):156-70. PubMed ID: 22436027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural polysaccharide-based biodegradable polymeric platforms for transdermal drug delivery system: a critical analysis.
    Noreen S; Ma JX; Saeed M; Pervaiz F; Hanif MF; Ahmed B; Farooq MI; Akram F; Safdar M; Madni A; Naveed M; Chang-Xing L
    Drug Deliv Transl Res; 2022 Nov; 12(11):2649-2666. PubMed ID: 35499715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan nanopolymers: An overview of drug delivery against cancer.
    Shanmuganathan R; Edison TNJI; LewisOscar F; Kumar P; Shanmugam S; Pugazhendhi A
    Int J Biol Macromol; 2019 Jun; 130():727-736. PubMed ID: 30771392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of chitosan and its water soluble derivatives-based drug carriers with polyelectrolyte complexes.
    Wu QX; Lin DQ; Yao SJ
    Mar Drugs; 2014 Dec; 12(12):6236-53. PubMed ID: 25532565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of HPMC - E15 LV premium polymer on release profile and compression characteristics of chitosan/ pectin colon targeted mesalamine matrix tablets and in vitro study on effect of pH impact on the drug release profile.
    Newton AM; Lakshmanan P
    Recent Pat Drug Deliv Formul; 2014 Apr; 8(1):46-62. PubMed ID: 24597626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects and challenges of anticancer agents' delivery via chitosan-based drug carriers to combat breast cancer: a review.
    Wang G; Li R; Parseh B; Du G
    Carbohydr Polym; 2021 Sep; 268():118192. PubMed ID: 34127212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical, pharmaceutical and biological approaches toward designing optimized and efficient hydrophobically modified chitosan-based polymeric micelles as a nanocarrier system for targeted delivery of anticancer drugs.
    Mahmoudzadeh M; Fassihi A; Emami J; Davies NM; Dorkoosh F
    J Drug Target; 2013 Sep; 21(8):693-709. PubMed ID: 23915108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.